HomeThemesTypesDBAbout
Showing: ◈ news×◈ medicine×
A senior Conservative MP has told PoliticsHome that he will be "seeking urgent clarification from the government" over reports time-sensitive cancer drugs were destroyed due to post-Brexit border delays.
Was the United Kingdom’s move to exit the European Union (EU) via BREXIT a bad move for biomedical research? According to a prominent academic investigator from the Imperial College of London, the move cost 2.5 million Euros ($2.52m USD) in research grants.
UK drug distributors and those involved in the parallel importing of drugs have told the parliamentary Health Select Committee that they want to see the UK remain in the customs union and the single market.
Health Minister Robin Swann has voiced concern about the supply line of medicines to Northern Ireland as a result of a looming Brexit regulatory barrier.
As of December 2022, UK companies importing medicines from the EU may need to set up new batch testing facilities. What will this mean for the industry and how did the situation come about?
Brexit has delayed Northern Ireland’s right to use a life-saving cancer drug in the same way as the UK.
Prime Minister Robert Abela has revealed that the United Kingdom’s exit from the EU has left Malta without its main legal vehicle to supply medical products to its residents, a leaked letter sent to the President of the European Council has revealed.
Brexit shut off the “relief valve” of immigration from the European Union, worsening workforce shortages in health and social care in the UK, a report from the Nuffield Trust think tank has concluded. / Brexit’s effect has been felt particularly in specialties such as cardiothoracic surgery and anaesthesia, and in dentistry and the care sector.
A report is warning the UK's medicine supply chain is "broken" with drug shortages becoming the "new normal" in Britain.
The supply of drugs, including of antibiotics, is being squeezed.
A report from the Nuffield Trust has concluded that the UK is facing “constantly elevated medicine shortages,” including some antibiotics and epilepsy drugs, which are being fuelled by Brexit.
Medical cannabis prescriptions can help reduce seizures in youngsters.
Brexit has increased drug prices and worsened staff shortages in the U.K., increasing the impact of other serious issues facing the country’s health care system, a report has found.
THE SEISMIC CHANGES to the relationship with our nearest neighbours and the impact of Brexit have only added fuel to the fire of severe challenges facing health and social care in the UK today, making people less healthy and widening health inequalities.
Generic makers have started to withdraw because they cannot afford to meet the costs of new post-Brexit red tape.
About 40 severely epileptic children are affected because supply of medical cannabis is terminated
Britain faces expulsion from a medical network that helps to identify and treat conditions that affect tens of thousands.
Firms already starting to withdraw vital drugs because of costly new red tape, says industry group.
Concession-priced medicine list is longest it has been since system was introduced.
The paper, commissioned by the Scottish Government, identified 137 potential impacts.
The UK’s official departure from the EU took place on January 1, 2021. The Brexit roll-out, not unexpectedly, has been awash with problems.
This week's Brexit downsides: half a billion in extra costs to import food, the collapse of trade talks with Canada and more.
Your weekly update from the Brexit ‘downside bunker’, chronicling the downsides, and occasional upsides, of Brexit.
There are growing post-Brexit differences between which medicines are approved for use in Northern Ireland and the rest of the UK, research from a health think tank indicates.